News Conference News ACC 2026 Hints of a Mortality Benefit With TTVR at 2 Years TRISCEND II Yael L. Maxwell April 07, 2026
News Conference News ACC 2026 Transcatheter ViV a Solid Option for Failed Mitral Bioprostheses: SURViV Caitlin E. Cox March 30, 2026
News Conference News ACC 2026 CHAMPION-AF: A Win for Watchman FLX, but With Caveats Todd Neale March 28, 2026
News Conference News ACC 2023 Self-Expanding TAVI Holds Up to Surgery Out to 3 Years in Low-Risk Patients Todd Neale March 05, 2023
News Conference News ACC 2022 Tricuspid Repair With Pascal Safe, Effective at 1 Year: CLASP TR Yael L. Maxwell April 05, 2022
News Conference News ACC 2021 Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC Michael O'Riordan May 17, 2021
News Conference News ACC 2019 POET: Oral Antibiotics Continue to Show Good Long-term Results for Endocarditis L.A. McKeown March 18, 2019
News Conference News ACC 2019 COAPT Echo Substudy in HF Patients With Mitral Regurgitation Offers New Answers, and More Questions Shelley Wood March 17, 2019